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Abstract
The use of microarray technology to measure gene expression on a genome-wide scale has been well established for
more than a decade. Methods to process and analyse the vast quantity of expression data generated by a typical
microarray experiment are similarly well-established.The Affymetrix Exon 1.0 STarray is a relatively new type of
array, which has the capability to assess expression at the individual exon level.This allows a more comprehensive
analysis of the transcriptome, andin particular enables the study of alternative splicing, a gene regulation mechanism
important in both normal conditions and in diseases. Some aspects of exon array data analysis are shared with
those for standard gene expression data but others present new challenges that have required development
of novel tools. Here, I will introduce the exon array and present a detailed example tutorial for analysis of data
generated using this platform.
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INTRODUCTION
Affymetrix have recently developed ‘whole tran-
script’ arrays, which are fundamentally different
to their traditional 30 expression arrays [1]. Probes
are designed along the entire length of the gene as
opposed to just the 30-end. Consequently, data from
all parts of the gene are available which avoids the
need to infer expression of the entire gene based on
measurements made at the 30-end. As well as giving a
better overall estimate of gene expression, it has the
added advantage so that expression of individual
exons can also be estimated.
The exon array consists of  1.4 million probesets
and >5 million individual probes. Each probeset
comprises four individual probes and usually corres-
ponds to a single exon (longer exons may have more
than one probeset designed to them). Again, there
are differences to the design of traditional 30 expres-
sion arrays, which have 11 probes per probeset, and
make use of ‘mismatch probes’, with the central base
mutated and intended to measure non-specific hy-
bridization. The exon array contains only perfect
match probes and non-specific hybridization is mea-
sured through two sets of negative control probes;
one set, referred to as ‘antigenomic background
probes’, is based on sequences having no match in
the human, mouse or rat genomes. The second set,
termed genomic background probes, are based on
probes designed to Genscan Suboptimal exon pre-
dictions (unlikely to be transcribed) from an old ver-
sion of the human genome (NCBI Build 31). In each
set, there are generally 1000 probes per GC-content
count (0–25 bases in the probe). This allows a
GC-based background correction to be performed
by matching the background signal to the GC con-
tent of each experimental probe, which is important
as the hybridization signal observed from control
probes tends to increase with GC content.
Probesets targeting individual exons can be further
grouped into ‘transcript clusters’ and gene-level
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all probes comprising a transcript cluster. The con-
tent of the exon array includes well-characterized
genes as well as more speculative regions of transcrip-
tion. Thus, it can potentially provide evidence for
novel transcripts in more exploratory experimental
designs. Depending on the level of evidence sup-
porting the existence of a particular exon, the pro-
besets are categorized as ‘core’ (annotated by
RefSeq), ‘extended’ (mRNA evidence) or ‘full’ (bio-
informatic prediction). The list of extended probesets
comprises those annotated as ‘core’ or ‘extended’ and
the list of full probesets includes ‘core’, ‘extended’
and ‘full’. The analysis at exon or gene level can be
restricted to any level of evidence as appropriate for
the study.
While the exon array can be used to analyse dif-
ferential gene expressions in exactly the same way
as traditional Affymetrix arrays, it has the advantage
of simultaneously providing data at the exon level.
Exon-level data can be used to investigate splicing
events, which determine how individual exons are
joined together to form a mature mRNA transcript.
Many genes exist as different isoforms, where the
exons at the gene locus are combined in different
ways to generate multiple forms of the gene. For
example, a cassette exon can give rise to two possible
transcripts—one form including the exon and the
other where it is ‘spliced out’ or skipped. There are
many variations of splicing events and they can be
combined together to generate a diverse set of tran-
scripts. Alternative usage of 30 sites, in particular, has
implications for the earlier 30 array design as shorter
isoforms of a gene may not be detected, resulting in
an incomplete estimate of gene expression.
Splicing is a highly regulated process and the idea
that aberrant splicing could underlie many diseases is
a very active area of research. The ability to investi-
gate splicing on a genome-wide scale using the exon
array is an exciting prospect. However, as is often the
case with such developments, new challenges in
terms of data analysis and interpretation can also
arise. I will demonstrate the use of Affymetrix
power tools (APT) [2] and R statistical software [3]
to process and analyse data from the exon array plat-
form. In particular, I will focus on data processing
and filtering steps necessary before running a splicing
analysis and briefly discuss ways to visualize and in-
terpret the results. It is important to note that the
methods presented here are just one way of ap-
proaching exon array data and many other tools
and software packages are available or are under de-
velopment in this fast-moving field.
Tools for exon array data analysis
APT is a suite of tools developed by Affymetrix for
processing and analysing data from any GeneChip
array and can be obtained from http://www
.affymetrix.com/partners_programs/programs/
developer/tools/powertools.affx#1_2.
Standard processing of exon array data can be per-
formed in APT with basic command line knowledge
but there is also scope for more advanced users to
adjust various parameters as well.
The R Statistical Software Package is a powerful,
open-source environment for statistical data analysis
and visualisation. It is available from http://www
.r-project.org/.
To demonstrate the use of APT and R to analyse
exon array data, I will use a publicly available data
set that used this platform to investigate splicing in
high and low hypoxia cancer samples [4]. The data
are available from the Gene expression omnibus
(GEO) [5] website http://www.ncbi.nlm.nih.gov/
geo/ by searching for the data set accession
number (GSE18300)—the record gives full informa-
tion on the study and access to the raw data files,
which can be downloaded and used to try out the
methods presented. APT has a web forum for users
and there is extensive documentation as well as a
mailing list for R—these are very useful places to
search if encountering any problems using the
software.
Processing exon array data using APT
As with other Affymetrix arrays, raw signal intensity
data are provided in .CEL files, each containing
probe-level intensities from a single array (sample).
These files can be processed in APT (as well as other
software packages) to generate exon- and gene-level
intensity estimates. As described above, probesets on
the exon array consist of four individual probes and
usually target a particular exon of a particular gene.
Thus, exon-level intensity estimates correspond to
the probeset-level estimates. Probesets are further
grouped into transcript clusters enabling a gene-level
estimate to be computed by summarizing data from
all probes within the transcript cluster. These two
values—the exon- and gene-level signal intensity es-
timates—form the basis of splicing analysis (discussed
in more detail below). First, we present methods to
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sion data using APT and further processing in R.
The ‘apt-probeset-summarize’ command reads in
raw CEL files and generates normalized exon- or
gene-level signal intensities, depending on the spe-
cified arguments [6]. To run the command, a num-
ber of files providing information on array design,
known as library files, are required. Affymetrix pro-
vide up-to-date versions of supporting files (library
files, annotation files, etc.) for each type of array they
manufacture.
The relevant files can be obtained from the
Affymetrix website (www.affymetrix.com) after
free registration for a username and password. At
the time of writing, the library files for the Human
Exon 1.0 ST array could be downloaded as a zip file
by locating the array name in the list of products on
the support page and checking the ‘library files’ box.
However, note that the organization of the website
and/or exact filenames may change over time. Click
the ‘Human Exon 1.0 ST Array Analysis’ link to
download the zip file. Unzip and check that the
following files are among those available:
HuEx-1_0-st-v2.r2.pgf
HuEx-1_0-st-v2.r2.clf
HuEx-1_0-st-v2.r2.antigenomic.bgp
HuEx-1_0-st-v2.r2.genomic.bgp
HuEx-1_0-st-v2.r2.qcc
The probe group file (.pgf) and cel layout file (.clf)
specify which probes belong to a given probeset and
their location in the cel file respectively. These two
files are used in place of the chip description file
(CDF) provided for other Affymetrix arrays. The
.bgp files contain information on background control
probes and the .qcc file has details of all control
probes. The library file package also includes a file
named HuEx-1_0-st-v2.r2.all.ps, which, when spe-
cified in the analysis, produces summary estimates for
all experimental probesets on the array. However, to
perform a gene-level analysis, or to restrict the ana-
lysis to a certain annotation level (core, extended or
full), additional files are needed. These can also be
obtained from the library files page, under the
‘Human Exon 1.0 ST Array Probeset and Meta
Probeset Files’ link.
The following six files should now be available:
HuEx-1_0-st-v2.r2.core.ps; HuEx-1_0-st-v2.r2.extended
.ps; HuEx-1_0-st-v2.r2.full.ps
HuEx-1_0-st-v2.r2.core.mps; HuEx-1_0-st-v2.r2.ex-
tended.mps; HuEx-1_0-st-v2.r2.full.mps
Exon-level analysis
To process the data at the exon (or probeset) level,
one of the .ps files should be specified; these simply
list the probeset IDs annotated at the chosen level
and the output contains summary estimates for the
specified probesets only. Various summary methods
are available within APT, including the RMA
(Robust multi-array average) [7] and PLIER
(Probe logarithmic intensity error) [8] algorithms,
which are both widely accepted methods for pro-
cessing Affymetrix microarray data. The processing
steps include background correction, normalization
and probeset summarization. RMA and PLIER are
both model-based methods, which aim to generate
robust signal estimates by down-weighing poorly
performing probes. For a variety of reasons, poor
probes would usually have low signal relative to
others in the probeset. Although alternatively spliced
exons could also have low signal (and therefore be
indistinguishable from a poor probe) RMA and
PLIER should be robust to this, specifically when
splicing is limited to a small proportion of exons
within the gene.
The following APT command can be used to
generate exon-level intensity estimates for core pro-
besets using RMA:
> apt-probeset-summarize -a rma-sketch
–p HuEx-1_0-st-v2.r2.pgf -c HuEx-1_0-
st-v2.r2.clf -s HuEx-1_0-st-v2.r2
.core.ps –qc-probesets HuEx-1_0-st-v2
.r2.qcc -o OUT_EXON *.CEL
A detailed description of each argument and notes
can be found in Table 1.
Gene-level analysis
To generate gene-level signal intensity estimates, one
of the *.mps files is specified in place of the *.ps file.
> apt-probeset-summarize –a rma-sketch
–p HuEx-1_0-st-v2.r2.pgf -c HuEx-1_0-
st-v2.r2.clf -m HuEx-1_0-st-v2.r2.core
.mps –qc-probesets HuEx-1_0-st-v2.r2
.qcc-o OUT_GENE *.CEL
Each *.mps file defines which probesets are asso-
ciated with each transcript cluster. Only probesets
classified as mapping uniquely to the genome are
636 Lockstonelisted, to avoid including signal from potentially
cross-hybridizing probes in the computation of the
gene-level signal estimate. It is worth noting that, in
the gene level, output from apt-probeset-summarize,
the column containing transcript cluster IDs is still
named probeset_id, but is not to be confused with
the exon level probeset_id. One decision regarding
the analysis workflow is whether to use core, ex-
tended or full probesets for the calculation of
exon/gene intensities. The more speculative content
of the array tends to introduce a lot of low intensity
noise from probes designed to regions that may
not be transcribed. Restricting to core probesets
should generate more reliable signal for the well-
characterized content and is particularly recom-
mended for the gene-level estimate.
Quality control of exon array data
The qcc argument to apt-probeset-summarize results
in the generation of a file containing summary meas-
ures for each array, which can be assessed to check
the quality of the data prior to analysis. As with other
types of microarray data, deciding whether to ex-
clude a sample as an outlier is dependent on a
number of factors; however, any sample behaving
differently to others in the experiment should be
considered carefully, specifically if flagged by mul-
tiple quality control (QC) measures. Full details on
the various metrics and control probes available on
the exon array and their interpretation is given in the
Affymetrix white paper on quality assessment [9].
To give a couple of examples, the pm_mean value
is the mean raw intensity for all probes on the
array—unusually bright or dim samples (high or
low pm_mean values respectively) should be handled
by normalization but this should be checked with
probeset-level metrics as well. The mean absolute
deviation (MAD) of the residuals for each chip
(from the RMA or PLIER model fit) compared to
the median for all chips is an useful metric for most
studies. An unusually high value for this metric
can suggest a problem with the given chip. Other
useful functions for assessing chip quality, including
identification of spatial artefacts, are available in the
Table 1: Using Affymetrix power tools to process raw data from the exon array and generate exon or gene-level
signal estimates
Example argument to apt-probeset-
summarize command
Notes
-a rma-sketch Specifies the analysis to be performed.‘rma-sketch’ (RMA using a subset of probes for
memory efficiency) is one of the standard options. Other options, such as plier-sketch
andplier-gcbg-sketch (incorporating a gc-basedbackground correction) canbe specified
instead. It is possible to perform multiple analyses simultaneously by including more
than one -a argument.
^p HuEx-1_0-st-v2.r2.pgf -c HuEx-1_0-st-v2.r2.clf Specify the library files, which give information on probeset groups and the array
layout. The ^p *.pgf and ^c *.clf arguments can be replaced with -d *.cdf if the user
wishes to use a custom CDF with alternative probeset definitions [24].
-s HuEx-1_0-st-v2.r2.core.ps If a .ps file is specified with the ^s argument, an exon-level analysis will be performed.
To run a gene-level analysis, a .mps file is specified with the ^m argument instead.
In either case, analysis can be restricted to probes annotated as core, extended or full
by specifying the relevant file.
^qc-probesets HuEx-1_0-st-v2.r2.qcc Specify the .qcc file to process the control probesets on the array and check quality of
data.
-o output_exon Specify a directory to write the output files with the ^o argument.This will be created
in the current working directory unless a path to another location is given. Output
files are named according to the analysis method (e.g. rma-sketch.summary.txt) and are
given the same name for both exon and gene-level analyses; they will be over-written
if another analysis is run with the same output folder specified. Therefore, it is useful
to write files to a new folder for each analysis. It is also helpful to re-name immediately
with an informative name to include the dataset, analysis method and whether it is an
exon or gene-level analysis to enable easy identification of the data in the file.
*.CEL Specify the .CEL files to be processed. If they are contained in the current working
directory, *.CEL will suffice, but a path to the files can be given if required. There will
be some differences between Windows and Linux systems regarding syntax for path
names and use of the wildcard (*) characterçWindows users will need to specify each
.CEL file to be analysed individually.
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(note that the CEL files will need to be processed
directly in R to create the required objects).
If the number of samples is small, the data in the
QC output file can be inspected by eye or otherwise
easily plotted for visualization in R:
> qc <- read.table("./OUT_EXON/rma-
sketch_core_exon.report.txt",
sep¼"\t", header¼T)
> plot(1:10, qc$pm_mean, ylim¼c
(0,1000), xlab¼"Array", ylab¼"Signal
Intensity", main¼"Average Raw Intensity
Signal")
> plot(1:10, qc$all_probeset_mad_
residual_mean, ylim¼c(0,0.3),
xlab¼"Array", ylab¼"Mean absolute
deviation", main¼"Deviation of
Residuals from Median")
Chip 8 has the highest MAD value (Figure 1) but as
it does not seem excessively high we would not
exclude this array unless further checks gave more
cause for concern. It is usually preferable to keep
arrays unless there is very good reason to exclude
them, as it reduces sample size, which is typically
small in the first place.
Visualizing the normalized data using hierarchical
clustering or density plots, e.g., can also be helpful to
check for outlier samples.
> d.exon <- read.table("./OUT_EXON/rma-
sketch_core_exon.summary.txt",
sep¼"\t", header¼T, row.names¼1)
> d.t <- dist(t(d.exon))
> plot(hclust(d.t), main¼"Hierarchical
clustering", labels¼c(rep("Low", 5),
rep("High", 5)))
Figure 1: Example quality control plots for the10 arrays in the example data set (GSE18300) showing (a) average
raw signal intensity; (b) mean residual deviation; (c) hierarchical clustering and (d) distribution of normalized
intensities.
638 Lockstone> plot(density(d.exon[,1]), main¼
"Distribution of RMA-normalised
intensities", xlab¼"RMA normalised
intensity")
> for(i in 2:ncol(d.exon)) {lines
(density(d.exon[,i]))}
The output from these plots is shown in
Figure 1 and suggests high-quality data from all
arrays. Furthermore, the low and high hypoxia
samples cluster into two groups, suggesting substan-
tial differential expression at the gene and/or exon
level.
At this point, it is useful to run another APT com-
mand to generate detection of P-values for each
probeset. ‘Detected above background’ or DABG
can be run as an analysis option to apt-probeset-
summarize:
> apt-probeset-summarize -a dabg -p
HuEx-1_0-st-v2.r2.pgf -c HuEx-1_0-st-
v2.r2.clf -b HuEx-1_0-st-v2.r2
.antigenomic.bgp-o ./OUT_DABG *.CEL
The signal intensity estimate obtained for each pro-
beset is compared to the signal distribution from the
set of anti-genomic probes (negative controls). The
degree of overlap is used to compute a detection
P-value, with P < 0.05, the usual threshold to con-
sider a probeset detected. The matrix of detection
P-values is written to a file called ‘dabg.summary.txt’
by default. This will be used later to filter for
detected exons and genes.
Once the data have been processed to generate
exon- and gene-level intensity estimates, it is useful
to import the data into the R statistical package for
further processing (in particular, filtering) before any
assessment of splicing. The exon-level data have
already been read into R for the quality checks, so,
now the gene-level data is needed:
> d.gene <- read.table("./OUT_GENE/
rma-sketch.summary_core_gene.txt",
sep¼"\t", header¼T, row.names¼1)
Signal intensity values from microarray experi-
ments are usually log-transformed to make the data
more appropriate for statistical analysis. The signal
intensity estimates will already be on log2 scale if
RMA was used to process the data but on the natural
scale if PLIER was used. Since PLIER estimates can
be close to zero, it is usual to add a small constant
(e.g. 16) to all values to stabilize the variance, prior to
log2 transforming the data.
## if processed with PLIER
> d.exon <- log2(d.exonþ16)
> d.gene <- log2(d.geneþ16)
The next step is to filter the data, which is critical in
the case of exon array data to reduce the
false-positive rate in the identification of potential
splicing events [12]. The two major types of filter
aim to remove probes with unusually low or high
signal, which could be artefacts mistaken for splicing
events. However, it is possible that stringent filtering
will also remove some true splicing events (e.g. low
signal intensity due to a poorly performing probeset
is indistinguishable from the low signal due to a
skipped exon). Thus, there is a balance between
reducing the false-positive rate, while keeping the
false-negative rate low as well. In practical terms, it
is better to focus on reducing the false-positive rate
to increase confidence in the splicing events that are
identified. This maximizes the chance of successful
validation (often required to confirm findings
suggested by microarray data), which can be expen-
sive and time-consuming.
Specific filtering steps recommended include:
(i) Restrict analysis to core probesets
(ii) Remove undetected probesets
(iii) Remove potentially cross-hybridizing probesets
(iv) Remove genes undetected in both groups of
samples
Each of these scenarios is discussed below, together
with sample R code to perform the suggested filter-
ing. The dimensions of various objects are given to
illustrate the inclusion of some commands; the reader
may find that their own data gives differing numbers
and possibly that minor modifications to the code
are needed if using the mouse/rat exon array or
there are changes to the Affymetrix file formats in
the future.
Filter for core probesets
As described earlier, core probesets are supported by
RefSeq annotations and are expected to give the
most reliable signal data. The analysis can easily be
restricted to core probesets by specifying the core.ps
and core.mps files in the exon- and gene-level pro-
cessing in APT as described above.
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Following the filter outlined in the Affymetrix tech-
nical note ‘identifying and validating alternative spli-
cing events’ [13], a probeset could be considered
detected when the DABG P < 0.05 in  50% of
the samples of at least one group. The rationale for
‘at least one group’ is that a skipped exon could be
entirely unexpressed in one group but present in
another.
> dabg <- read.table("./OUT_DABG/
dabg.summary.txt", sep¼"\t", header¼T,
row.names¼1)
> dim(dabg) # 1411399 10
> dabg.core <- dabg[match(row.names
(d.exon), row.names(dabg)),]
> dim(dabg.core) # 287329 10
## define a function to count how many samples
have a detection P < 0.05 and apply to each group
separately
> count.det <- function(x){length
(which(x<0.05))}
> group1.det <- apply(dabg.core[,1:5],
1, count.det)
> group2.det <- apply(dabg.core
[,6:10], 1, count.det)
## retain probesets with P < 0.05 in three or more
samples in at least one group
> x <- sort(union(which(group1.det>
¼3), which(group2.det>¼3)))
> d.exon.fil <- d.exon[x,]
> dim(d.exon.fil) # 224600 10
Filter for cross-hybridizing probesets
Cross-hybridizing probesets may have artificially
high signals due to more than one RNA product
hybridizing to them. They are not included in the
*.mps files to ensure that gene-level estimates are as
reliable as possible, but are in the exon level *.ps files.
Thus, exon-level signals from these probesets may
suggest an increased rate of inclusion of that exon,
but would be false positives if the additional signal
comes from another RNA product. Such probesets
can easily be filtered out using information in the
exon array annotation file (current release is HuEx-
1_0-st-v2.na30.hg19.probeset.csv).
The latest annotation file for the Human Exon 1.0
ST array can be obtained from the Affymetrix web-
site by locating the product in the drop-down menu
on the support page and checking the box for anno-
tation files. Scroll down to find the files under the
heading ‘Current NetAffx Annotation Files’ and
choose the ‘HuEx-1_0-st-v2_Probeset_Annotations,
CSV Format’ link.
Download and unzip the file, then read into R:
> annot <- read.table("HuEx-1_0-st-v2
.na30.hg19.probeset.csv", sep¼",",
header¼T)
> dim(annot) # 1422046 39
## reduce annotation table to core probesets passing
the detection filter:
> annot.core <- annot[match(row.names
(d.exon.fil), annot[,1]),]
> dim(annot.core) # 224600 39
> colnames(annot.core)
## keep only probesets with a value of 1 in the
crosshyb_type column (map uniquely)
> keep <- which(annot.core$crosshyb_
type¼¼1) # rows containing non-cross-
hybridizing probesets
> ids <- annot.core[keep,1] # extract
corresponding probeset IDs
> d.exon.fil2 <- d.exon.fil[match(ids,
row.names(d.exon.fil)),]
> dim(d.exon.fil2) # 179445 10
> write.table(d.exon.fil2, "./
OUT_EXON/rma-sketch.summary_core_
exon_filtered.txt", sep¼"\t", quote¼F,
row.names¼T)
Filter for genes undetected in both
groups
If a gene is not expressed overall in either of the
groups being investigated, the concept of differential
splicing becomes meaningless and it is therefore
useful to remove any genes, as well as probesets,
considered undetected. The DABG value is only ap-
propriate at the probeset (exon) level, but simple
criteria can be defined to decide if the gene should
be considered expressed overall. For example, it
might be reasonable to call a gene expressed in a
particular sample if more than one-half its
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0.05. To be considered expressed in a group overall,
we might require that it is detected in more than
one-half the samples of that group. This filter has a
few more steps than the probeset detection filter but
follows the same principles. First, use the annotation
table to add transcript cluster ID as an extra column
in the dabg.core detection matrix:
> dim(dabg.core) # 287329 11
> length(intersect(row.names(dabg
.core), annot[,1]))# 286876 – 453 probe-
set IDs are missing from annotation file
(likely to be control probes). Remove
these to avoid NAs later on
> keep <- intersect(row.names(dabg
.core), annot[,1])
> dabg.core2 <- dabg.core[match(keep,
row.names(dabg.core)),]
> dim(dabg.core2) # 286876 10
> dabg.core2[,11] <- annot[match(row
.names(dabg.core2), annot$probeset
_id), 7] # look up transcript cluster IDs
> gene.ids <- unique(dabg.core2[,11])
> length(gene.ids) # 18705
Now, define a function to calculate the proportion
of probesets with P < 0.05—this will be applied to
each sample for each gene:
count.exon.det <- function(x){length
(which(x<0.05))/length(x)}
Create an empty matrix to store results from apply-
ing the above function:
> gene.detection <- matrix(nrow¼length
(unique(dabg.core2[,11])), ncol¼10)
> row.names (gene.detection) <- gene
.ids
> colnames(gene.detection) <- colnames
(d.gene)
Apply the function to each sample in turn:
> for(i in 1:10)
{
gene.detection[,i] <- tapply(dabg
.core2[,i], dabg.core2[,11],
count.exon.det)
}
Now, another function is needed to count how
many samples in each group the gene was detected
in (i.e. more than half the probesets were detected):
> count.gene.det <- function(x){length
(which(x>¼0.5))}
> genes.det.group1 <- apply(gene.
detection[,1:5], 1, count.gene.det)
> genes.det.group2 <- apply(gene.
detection[,6:10], 1, count.gene.det)
Keep genes where both counts are  3 (i.e. more
than one-half the samples in the group):
> keep.genes <- which((genes.det.
group1>¼3)&(genes.det.group2>¼3)) #
row numbers
> length(keep.genes) # 13211
> keep.gene.ids <- row.names (gene.
detection)[keep.genes]
## look up these gene ids in the gene summary
matrix
> length(intersect(keep.gene.ids,
row.names(d.gene))) # 12642 – this tells
us that 569 genes are not in the gene
summary output — they are missing because
these genes have no core probesets that
map uniquely —
> y <- match(keep.gene.ids, row.names
(d.gene))
## remove the NAs
> y <- y[-which(is.na(y)¼¼"TRUE")]
> d.gene.fil <- d.gene[y,]
> dim(d.gene.fil) # 12642 10
> write.table(d.gene.fil, "./OUT_GENE
/rma-sketch.summary_core_gene_
filtered.txt", sep¼"\t", quote¼F,
row.names¼T)
Splicing analysis
To identify exons of a gene that are alternatively
spliced, the concept of the splicing index has been
introduced [14]. In the absence of alternative spli-
cing, the expression level of each exon is expected to
be similar and to the expression level of the gene
overall (i.e. each and every exon is included in the
gene product. The exon to gene ratio is therefore
expected to be close to one. The splicing index is
defined as the log2 ratio of exon to gene intensity.
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equal zero, while a skipped exon would generate a
negative value and an exon included at a higher rate
than others would generate a positive value. Usually,
it is of interest to identify differential exon usage
between two samples or groups of samples, as this
could indicate preferential expression of one isoform
over another with potential biological consequences.
Several tools can be used to identify differential spli-
cing, including the APT program MiDAS [15], the
‘limma’ package from BioConductor [16, 17], a spe-
cialised R package called ExonMap [18] and com-
mercial software such as Partek Genomics Suite [19].
This is an active area of research but the basis of these
tools is to use an ANOVA approach to identify
exons behaving differently to others at the same
gene locus. Another R package ‘aroma.affymetrix’
[20] has comprehensive methods for both processing
exon array data and detection of alternative splicing
(FIRMA: Finding isoforms using robust multichip
analysis) [21].
To continue the demonstration of APT for exon
array data analysis, I will briefly outline an example
splicing analysis using the MiDAS tool. MiDAS can
be run directly on the exon and gene-level summa-
ries generated by the apt-probeset-summarize com-
mand; however, as noted above, it is important to
filter the files to remove potential artefacts before
running any splicing analysis. The filtered files are
then provided as input to MiDAS.
First, a text file describing the samples in your
experiment containing two columns is required:
the first column should have the header ‘cel_files’
and list the names of the .CEL files corresponding
to the samples to be analysed (note that the filenames
have to be exactly correct to be recognized—they
will also be the column headers in the exon/gene
summary files); the second column should have the
header ‘group_id’—this can contain arbitrary names
that describe the group each sample belongs to (sam-
ples assigned the same name will be considered as
one group). MiDAS is an ANOVA-based test, so
two or more groups can be analysed simultaneously
and at least three samples per group are required to
estimate the variance. Run MiDAS with the follow-
ing command:
> apt-midas –cel-files cels.txt –g ./
OUT_GENE/rma-sketch_core_gene.sum-
mary_filtered.txt –e ./OUT_EXON/rma-
sketch_core_exon.summary_filtered.txt
–m HuEx-1_0-st-v2.r2.core.mps –o ./
OUT_MIDAS –nol
By default, the apt-midas command log transforms
the data—this is only applicable to PLIER estimates
and needs to be switched off if using RMA data (or if
you have already log2 transformed PLIER estimates)
with the –nol argument.
The results file generated by MiDAS contains a list
of the probesets that have passed filtering and an asso-
ciated raw P-value for differential splicing of the exon
targeted by that probeset. It can be read into R and
sorted on P-value to find the exons most likely to be
interesting in terms of alternative splicing:
> midas <- read.table("midas.pvalues
.txt", sep¼"\t", header¼T)
> head(midas)
> o <- order(midas$pvalue)
> midas.ordered <- midas[o,]
Further filtering based on P-value and/or magnitude
of the splicing index (analogous to fold change
filter in standard gene expression analyses) can be
applied to generate a shortlist. Currently, MiDAS
doesn’t output the SI value, but it can be computed
in R as the difference between the log scale exon and
gene intensities. Manual inspection of the data can
be very useful at this point to decide which genes to
follow-up.
Interpreting the results from a splicing analysis
can be the most challenging aspect of exon array
analysis. In some situations, differential splicing can
be dramatic; e.g. a large number of brain-specific
isoforms have been found in tissue comparisons
[22]. However, in many common analysis scenarios,
there may only be a subtle change in the relative
proportions of different isoforms between samples/
groups, which can be difficult both to detect and
interpret.
The first step in trying to understand the biology
underlying an exon identified as differentially spliced
is to place the data in the context of known isoforms
of that gene. APT does not have any visualization
capabilities but again, other tools are available for this
purpose. In particular, the R package ExonMap
[18] and commercial software Partek Genomics
Suite [19] both perform analysis of splicing and pro-
vide excellent visualization functions. Another pos-
sibility is looking at the gene of interest in the UCSC
Genome Browser [23], giving access to full details of
642 Lockstoneknown and predicted genes/mRNAs from a wide
variety of sources. This can be very useful to pinpoint
splicing that affects an exon that has been predicted
but is not part of the RefSeq transcripts for example.
Another useful feature of the UCSC Genome
Browser is that a track showing the location of
exon array probesets can also be displayed, allowing
cross-referencing between the splicing results and
gene structure information. Finally, with some R
code, it is relatively straightforward to generate a
graph of the data for a particular gene, which can
be coloured for each group.
In summary, data generated with the exon array
has the potential to give deeper biological insights
into gene expression and regulation, particularly
with regard to splice isoforms, than standard gene
expression arrays. A range of tools are available to
analyse these data, drawing on previous algorithms
for microarray expression data or novel approaches
specific for exon arrays. Similar analyses can now be
performed with next-generation sequencing tech-
nology and this will undoubtedly become more rou-
tine with reducing costs, increased read counts and
development of appropriate tools. However, analysis
of alternative splicing and isoform representation is
arguably one of the most challenging aspects of
RNA-Seq data and the exon array will remain an
extremely useful platform in this transition period.
Key Points
  The exon array has the potential to give deeper biological
insights into gene expression and regulation, particularly, alter-
native splicing, than standardgene expression arrays.
  It presents new challenges in terms of data analysis and can
produce a high rate of false positive differential splicing events
withoutcareful filtering of the data first.
  Anumberof toolshavebeendevelopedforanalysisofexonarray
dataçthis review focuses on the suite of tools developed
by Affymetrix and the statistical softwarepackage R.
  Thetutorialstepspresentedhererepresentjustoneof themany
possible approaches to exon arraydata analysis.
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